Epigenomics AG Share Price Xetra
Equities
DE000A1K0516
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.5M 1.63M 128M |
---|---|---|---|---|---|
Net income 2024 * | - 0 0 | Net income 2025 * | - 0 0 | EV / Sales 2024 * | - |
Net cash position 2024 * | 2.48M 2.69M 212M | Net cash position 2025 * | 1.39M 1.51M 119M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.91
x | P/E ratio 2025 * |
-2.97
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.77% |
Managers | Title | Age | Since |
---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
Annett Dietrich
HRO | Human Resources Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Helge Lubenow
CHM | Chairman | 56 | 24/05/16 |
Jochen Hummel
BRD | Director/Board Member | 54 | 02-04 |
Alexander Link
BRD | Director/Board Member | 53 | 31/05/20 |
1st Jan change | Capi. | |
---|---|---|
-31.90% | 9.59B | |
-6.25% | 3.21B | |
+25.95% | 2.92B | |
-13.96% | 2.15B | |
-16.83% | 1.79B | |
+72.82% | 1.47B | |
+29.17% | 770M | |
-2.62% | 761M | |
-26.33% | 548M |